GRML (Greenland Mines) Total Stockholders Equity: $9.46 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GRML Greenland Mines Ltd GRML
12 GF Score
Price $5.04
View Full Analysis

What is Greenland Mines Total Stockholders Equity?

Greenland Mines GRML -48.04% 12 Total Stockholders Equity is $9.46 Mil as of Dec. 2025. GuruFocus rates GRML with a GF Score™ of 12/100.

Greenland Mines's Total Stockholders Equity for the quarter that ended in Dec. 2025 was $9.46 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Greenland Mines's Book Value per Share for the quarter that ended in Dec. 2025 was $3.90. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Greenland Mines's Debt-to-Equity for the quarter that ended in Dec. 2025 was 0.00.

Greenland Mines  (NAS:GRML) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Greenland Mines's Book Value per Share for the quarter that ended in Dec. 2025 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(9.463-0)/2.425
=3.90

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Greenland Mines's Debt-to-Equity for the quarter that ended in Dec. 2025 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 9.463
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Greenland Mines Total Stockholders Equity Related Terms

Greenland Mines Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Greenland Mines's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Greenland Mines Total Stockholders Equity Chart

Greenland Mines Annual Data
Trend Dec24 Dec25
Total Stockholders Equity
1.19 9.46

Greenland Mines Semi-Annual Data
Dec24 Dec25
Total Stockholders Equity 1.19 9.46
GRML
12GF Score
Greenland Mines Ltd GRML
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of $9.46 Mil mean?
Greenland Mines (GRML) has a Total Stockholders Equity of $9.46 Mil as of Dec. 2025. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Greenland Mines and its competitors.
Is Greenland Mines' Total Stockholders Equity too high?
Greenland Mines' current Total Stockholders Equity is $9.46 Mil. Overall, Greenland Mines has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Greenland Mines' Total Stockholders Equity compare to SRGZ and DYNR?
Greenland Mines' Total Stockholders Equity of $9.46 Mil can be compared against companies in the Metals & Mining industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Metals & Mining company?
A good Total Stockholders Equity depends on the Metals & Mining industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Greenland Mines and its competitors. Greenland Mines's current Total Stockholders Equity is $9.46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Greenland Mines stock overvalued right now?
Greenland Mines (GRML) has a current Total Stockholders Equity of $9.46 Mil. The current Total Stockholders Equity is $9.46 Mil. Greenland Mines' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Greenland Mines (GRML), the current Total Stockholders Equity is $9.46 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Greenland Mines Business Description

Address 1300 South Boulevard, Unit D, Charlotte, NC, USA, 28203
Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.
12GF Score

Get the complete analysis for GRML

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.04
Price